Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.

Getting a colonoscopy can be a daunting idea. However, the reality is that a colonoscopy is a routine outpatient procedure ...

Most federal prisoners at average risk of colorectal cancer aren't screened annually, and treatment often lagged, a watchdog ...

In the treatment group, 70.9% had prior nasal polyp surgery, with a mean of 7.71 years since the most recent surgery. In the placebo group, 71.7% had prior nasal polyp surgery, with a mean of 7.68 ...

Treatment with Tezspire significantly reduced nasal polyp severity measured by the co-primary endpoints; Nasal Polyp Score (NPS) by -2.065 (95% CI: -2.389, -1.742; p<0.0001) and nasal congestion ...

Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps, but its efficacy and ...

Most endometrial polyps do not return after treatment. Only about 2.5-3.7% of cases return. If you have signs of irregular bleeding, heavy periods, bleeding between periods, pain, or trouble ...

Biologics. Surgery. These are some of the treatments your doctor may have recommended to manage your nasal polyps. The ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...